CADTH Is Now Canada's Drug Agency

MT
McCarthy Tétrault LLP
Contributor
McCarthy Tétrault LLP provides a broad range of legal services, advising on large and complex assignments for Canadian and international interests. The firm has substantial presence in Canada’s major commercial centres and in New York City, US and London, UK.
As of May 1, 2024 CADTH is no more, as it adopts its new operating name: Canada's Drug Agency (the "CDA"). The CDA expands on CADTH's existing mandate and functions to include:
Canada Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

As of May 1, 2024 CADTH is no more, as it adopts its new operating name: Canada's Drug Agency (the "CDA"). The CDA expands on CADTH's existing mandate and functions to include:

  1. improving the appropriate prescribing and use of medications;
  2. increasing pan-Canadian data collection and expanding access to drug and treatment data, including real-world evidence data; and
  3. reducing drug system duplication and lack of coordination.

The CDA will be providing updates over the coming months regarding these new mandates.

To view the original article click here

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

CADTH Is Now Canada's Drug Agency

Canada Food, Drugs, Healthcare, Life Sciences
Contributor
McCarthy Tétrault LLP provides a broad range of legal services, advising on large and complex assignments for Canadian and international interests. The firm has substantial presence in Canada’s major commercial centres and in New York City, US and London, UK.
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More